Table 1. Compounds 1–4: Activity against Src and ADME propertiesa.
Cpd | Aqueous Solubility (μg/mL) | LogPb | Src (Ki μM) | PAMPA (10−6 cm2/sec) | MRc (%) | Metabolic Stabilityd (%) |
---|---|---|---|---|---|---|
1 | 0,21 | 6,555 | 3.7 | 3.98 | 46.8 | 95.8 |
2 | 3,71 | 5,813 | 0.13 | 5.27 | 46.1 | 96.0 |
3 | 0,22 | 5,678 | 0.4 | 5.51 | 48.9 | 97.9 |
4 | 0,90 | 5,992 | 0.01 | 4.53 | 49.6 | 93.5 |
aAll the data were previously reported, see supporting material for experimental details25,26,27.
bCalculated by Qikprop.
cMembrane Retention (MR) expressed as percentage of compound unable to reach the acceptor compartment.
dExpressed as percentage of unmodified drug.